Fund Name | : | Mirae Asset Mutual Fund |
Scheme Name | : | Mirae Asset Healthcare Fund - Regular (G) |
AMC | : | Mirae Asset Mutual Fund |
Type | : | O |
Category | : | Equity - Pharma |
Launch Date | : | 11-Jun-2018 |
Fund Manager | : | Vrijesh Kasera |
Net Assets (Rs. cr) | : | 2235.15 |
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
NAV Date | : | 22-Apr-2024 |
NAV [Rs.] | : | 30.68 |
Buy/Resale Price [Rs.] | : | 0 |
Sell/Repurchase Price [Rs.] | : | 0 |
Entry Load % | : | Nil |
Exit Load % | : | 1.00% - If redeemed within 1 year (365 days) from the date of allotment Nil - If redeemed after 1 year (365 days) from the date of allotment |
1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
---|---|---|---|---|---|---|---|---|
Scheme Returns | -0.19 | 0.44 | 4.86 | 20.84 | 46.63 | 14.83 | 23.60 | 21.28 |
Category Avg | -1.75 | 2.39 | 4.75 | 21.86 | 48.93 | 15.89 | 22.98 | 18.74 |
Category Best | -0.47 | 6.66 | 7.70 | 26.46 | 57.12 | 18.83 | 27.18 | 36.35 |
Category Worst | -0.19 | 0.44 | 4.86 | 20.84 | 46.63 | 14.83 | 23.60 | 21.28 |
Dividends | Bonus |
---|
No Record Found
Min. Investment(Rs.) | : | 5000 |
Increm.Investment(Rs.) | : | 1000 |
Calculate the worth of your wealth at retirement
In | |
Name of the Company | No of shares |
No Record Found
Out | |
Name of the Company | No of shares |
No Record Found
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) | ||||
---|---|---|---|---|---|---|---|---|---|
Equity & Equity related Investments | |||||||||
Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 14.92 | 20,58,051.00 | 333.52 | ||||
Equity | Cipla | Pharmaceuticals & Biotechnology | 9.62 | 14,35,827.00 | 214.94 | ||||
Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 8.25 | 16,93,059.00 | 184.33 | ||||
Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 7.17 | 2,60,346.00 | 160.32 | ||||
Equity | Apollo Hospitals | Healthcare Services | 6.34 | 2,22,799.00 | 141.63 | ||||
Equity | J B Chem & Pharm | Pharmaceuticals & Biotechnology | 4.61 | 6,23,974.00 | 102.98 | ||||
Equity | Krishna Institu. | Healthcare Services | 4.23 | 4,59,000.00 | 94.52 | ||||
Equity | Lupin | Pharmaceuticals & Biotechnology | 4.20 | 5,80,370.00 | 93.83 | ||||
Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 4.10 | 4,96,837.00 | 91.68 | ||||
Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 3.83 | 3,29,135.00 | 85.59 | ||||
Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 3.52 | 2,28,412.00 | 78.69 | ||||
Equity | Fortis Health. | Healthcare Services | 3.46 | 18,40,491.00 | 77.34 | ||||
Equity | Max Healthcare | Healthcare Services | 2.44 | 6,65,000.00 | 54.52 | ||||
Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.31 | 5,13,201.00 | 51.70 | ||||
Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.99 | 1,99,644.00 | 44.54 | ||||
Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.94 | 3,49,571.00 | 43.26 | ||||
Equity | Syngene Intl. | Healthcare Services | 1.93 | 6,13,543.00 | 43.10 | ||||
Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.93 | 87,093.00 | 43.04 | ||||
Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 1.91 | 4,45,121.00 | 42.66 | ||||
Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 1.74 | 1,68,695.00 | 38.81 | ||||
Equity | Max Financial | Insurance | 1.35 | 3,01,231.00 | 30.19 | ||||
Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.27 | 4,83,556.00 | 28.32 | ||||
Equity | Dr Lal Pathlabs | Healthcare Services | 1.20 | 1,18,267.00 | 26.76 | ||||
Equity | Vinati Organics | Chemicals & Petrochemicals | 1.08 | 1,63,822.00 | 24.09 | ||||
Equity | Biocon | Pharmaceuticals & Biotechnology | 0.96 | 8,13,919.00 | 21.50 | ||||
Equity | Natco Pharma | Pharmaceuticals & Biotechnology | 0.92 | 2,16,673.00 | 20.63 | ||||
Equity | Sanofi India | Pharmaceuticals & Biotechnology | 0.82 | 22,537.00 | 18.29 | ||||
Equity | Tatva Chintan | Chemicals & Petrochemicals | 0.70 | 1,45,844.00 | 15.73 | ||||
Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 0.51 | 2,90,000.00 | 11.38 | ||||
Equity | Jupiter Life Lin | Healthcare Services | 0.32 | 60,226.00 | 7.21 | ||||
Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.02 | 3,597.00 | 0.55 | ||||
Equity | Abbott India | Pharmaceuticals & Biotechnology | 0.00 | 2.00 | 0.01 | ||||
Cash & Cash Equivalent | |||||||||
Reverse Repo | TREPS | -/- | 0.52 | 0.00 | 11.63 | ||||
Net CA & Others | Net CA & Others | -/- | -0.10 | 0.00 | -2.34 | ||||
Mutual Fund Investments | |||||||||
Indian Mutual Funds | Mirae Asset Liquid Fund - Direct (G) | -/- | 0.01 | 815.00 | 0.21 |
Fund House | : Mirae Asset Investment Managers (India) Pv |
Incorporation Date | : 20-Nov-2006 |
Total Assets Managed (Cr.) | : 1,64,467.60 |
Trustee/s | : Mirae Asset Trustee Compa |
Chairman | : N/A |
CEO / MD | : Swarup Anand Mohanty |
CIO | : N/A |
President | : N/A |
Director/s | : Mr. Swarup Mohanty |
Compliance Officer/s | : Ms. Rimmi Jain |
Investor Service Officer/s | : N/A |
Fund Manager/s | : Vrijesh Kasera |
Auditors | : N/A |
Registered Office | : Unit 606,6th Flr,Windsor Off. CST Road,Kalina, Santacruz(E),Mumbai-400098 |
Contact Nos | : 022-67800300 |
Fax | : 022-67253942 |
: customercare@miraeasset.com | |
Website | : www.miraeassetmf.co.in |
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.